Laurie Stelzer, Chief Financial Officer at HALOZYME THERAPEUTICS INC (HALO), bought 10,000 shares at $17.24 ($172K) on 2015-08-20, disclosed to the SEC on 2015-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.